NASDAQ:AQST

Aquestive Therapeutics Stock Insider Trading

Healthcare > Drug Manufacturers - Specialty & Generic

Buy AQST

*Your capital is at risk

$4.06

-0.0600 (-1.46%)

At Close: Jul 13, 2026

Aquestive Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -56.31. In total, the insiders bought 3.94M and sold 1.71M AQST shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-56.31
● Buy	3.94M shares
● Sell	1.71M shares
64% Buy Activity Weak Negative Correlation
Sell Signal Medium Confidence Mar 10, 2026 Analysis Breakdown: Strongly supported by a very low Insider Power Score of -56.31. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jun 23, 2026 Sell	Common Stock S-Sale	Krop Julie Director	Director	25 000 Value: $125.4K
Jun 23, 2026 Buy	Common Stock M-Exempt	Krop Julie Director	Director	25 000 Value: $17.8K
Jun 23, 2026 Buy	Non-Qualified Stock Option (right to buy) M-Exempt	Krop Julie Director	Director	25 000 Value: $17.8K
Jun 15, 2026 Sell	Common Stock S-Sale	Barber Daniel President And CEO	CEO / President	25 000 Value: $104.0K
Jun 10, 2026 Buy	Stock Option (Right to Purchase) A-Award	Taglietti Marco Director	Director	50 500 Value: $201.5K
Jun 10, 2026 Buy	Stock Option (Right to Purchase) A-Award	Brown Gregory B Director	Director	50 500 Value: $201.5K
Jun 10, 2026 Buy	Stock Option (right to purchase) A-Award	Morris Timothy E Director	Director	50 500 Value: $201.5K
Jun 10, 2026 Buy	Stock Option (Right to Purchase) A-Award	Krop Julie Director	Director	50 500 Value: $201.5K
Jun 10, 2026 Buy	Non-Qualified Stock Option (right to buy) A-Award	Jenkins Abigail L. Director	Director	50 500 Value: $201.5K
Jun 10, 2026 Buy	Stock Option (Right to Purchase) A-Award	Cochran John Director	Director	50 500 Value: $201.5K
Jun 08, 2026 Sell	Common Stock F-InKind	Korczynski Sherry Chief Commercial Officer	Officer	2 714 Value: $0
May 18, 2026 Buy	Common Stock A-Award	Zalewski Thomas A. Chief Legal Officer	Officer	100 000 Value: $413.5K
May 18, 2026 Buy	Non-Qualified Stock Option (right to buy) A-Award	Zalewski Thomas A. Chief Legal Officer	Officer	75 000 Value: $310.1K
May 15, 2026 Sell	Common Stock S-Sale	Barber Daniel President And CEO	CEO / President	8 257 Value: $35.4K
May 15, 2026 Sell	Common Stock F-InKind	Cioffi Melina SVP, Regulatory Affairs	Officer	1 667 Value: $7K
May 07, 2026 Sell	Common Stock F-InKind	Braender Lori J Corporate Secretary	Officer	135 690 Value: $574.0K
May 05, 2026 Sell	Common Stock F-InKind	Boyd Peter E. Chief People Officer	Officer	56 778 Value: $237.3K
May 05, 2026 Sell	Common Stock F-InKind	Barber Daniel President And CEO	CEO / President	335 922 Value: $1.40M
May 05, 2026 Sell	Common Stock F-InKind	Toth A Ernest Jr Chief Financial Officer	C-Suite Officer	92 652 Value: $387.3K
May 05, 2026 Sell	Common Stock F-InKind	Jung Cassie Chief Operating Officer	C-Suite Officer	72 734 Value: $304.0K
May 05, 2026 Sell	Common Stock F-InKind	Braender Lori J Corporate Secretary	Officer	76 147 Value: $318.3K
Apr 02, 2026 Buy	Common Stock	Zalewski Thomas A. Chief Legal Officer	Officer	0 Value: $0
Mar 10, 2026 Sell	Common Stock S-Sale	Toth A Ernest Jr Chief Financial Officer	C-Suite Officer	58 254 Value: $243.1K
Mar 10, 2026 Sell	Common Stock S-Sale	Cioffi Melina SVP, Regulatory Affairs	Officer	25 311 Value: $105.6K
Mar 10, 2026 Sell	Common Stock S-Sale	Braender Lori J Chief Legal Officer	Officer	40 102 Value: $167.3K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT AQUESTIVE THERAPEUTICS INC.

Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Zuplenz, an oral ...

Read Full Profile Here